Portfolio Management Services (PMS)
Compare Schemes

Invasset - Growth Fund vs Valcreate Lifesciences and Specialty Opportunities

Invasset - Growth Fund
Valcreate Lifesciences and Specialty Opportunities
Add Scheme
Growth of ₹1 Crore
Invasset - Growth Fund
Valcreate Lifesciences and Specialty Opportunities
Return for the risk
3 yrs return
5%
10%
15%
20%
25%
Nifty 500 · 12.1%
10%
20%
30%
Volatility • 3 yrs deviation
1 Month
0.38%
6.35%
6 Months
2.78%
17.95%
1 Year
6.76%
21.71%
3 Years
15.24%
19.34%
5 Years
18.34%
—
Since Inception
26.15%
19.34%
Fund Age
6 yrs 7 mo
3 yrs 6 mo
AUM
₹332.83 Cr
₹18.73 Cr
Alpha – 1 Year
2.04%
16.99%
Alpha – 3 Years
3.15%
7.25%
Information Ratio – 3 Years
0.19
0.85
Volatility – 1 Year
21.45%
22.22%
Volatility – 3 Years
23.36%
20.72%
Beta – 1 Year
1.03
0.87
Beta – 3 Years
1.11
0.89
Sharpe Ratio – 1 Year
0.16
0.75
Sharpe Ratio – 3 Years
0.50
0.85
Worst Rolling Year
15.25%
—
Value at Worst Rolling Year
₹1.15 Cr
—
Deepest Drawdown
−32.29%
—
Recovery Period
Not yet recovered
—
1-Year Rolling Windows Positive
100.00%
—
Median Rolling Year
33.37%
—
5-Year Rolling Windows Positive
100.00%
—
Market-Cap Mix
L 20% · M 5%
—
Number of Stocks
11
—
Portfolio P/E
—
—
Top 5 Holdings
Cash & Cash Equivalent · 100.00%
Sharda Cropchem Ltd · 11.13%
Kwality Pharmaceuticals Ltd · 5.72%
Sumitomo Chemical India Ltd · 5.72%
Vinati Organics Ltd · 5.51%
Rallis India Ltd · 5.34%
Top Sectors
—
—
Fixed Fee
0.00% / yr
2.50% / yr
Performance Fee / Plan
20% of profit, above 0%
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
2% / 0% / 0%
0% / 0% / 0%
Let's start a
conversation
  • Compare this PMS against 3,000+ others with our research desk
  • Build a long-term portfolio around your goals, not a one-off buy
  • Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.
Start a conversation
Share a few details and an expert will reach out.
We will only use these details to contact you about this enquiry. No spam.